Status: Recruiting
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
The goal of this clinical trial is to learn if bronchoscopic lung volume reduction with endobronchial thermal liquid ablation (ETLA) works to treat severe emphysema in terms of feasibility and safety. Participants will: * Have up to two ETLA procedures * Complete five clinic follow-up visits and two virtual follow-up visits.
Participants needed: 30
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Morair Medtech, LLCUpdated: Jan 28, 2025Locations: 7
Eligibility criteria
Age ≥ 40 years old [+14]
Body mass index (BMI) < 16 kg/m² or ≥ 33 kg/m² [+33]